Pooled Testing for SARS-CoV-2 in Hospitalized Patients.
J Hosp Med
; 15: 538-539, 2020 07.
Article
in English
| MEDLINE | ID: covidwho-725053
ABSTRACT
Viral testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), particularly early in the COVID-19 pandemic, was limited by supply of reagents. We pooled nasopharyngeal samples from patients at low risk of SARS-CoV-2 infection in groups of 3 for testing. Three weeks of testing using this strategy resulted in 530 patient tests in 179 cartridges; 4 positive test groups required the use of 11 additional cartridges with an overall positive rate of 0.8% in a low-risk population. This strategy resulted in the use of 340 fewer cartridges than if each test were performed on one patient sample. Pooled testing of low-risk populations allows for continued testing even when supplies are relatively scarce.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
DNA, Viral
/
Genetic Testing
/
Coronavirus Infections
/
Pandemics
/
Betacoronavirus
/
Inpatients
Type of study:
Diagnostic study
/
Experimental Studies
/
Observational study
/
Prognostic study
/
Randomized controlled trials
Limits:
Humans
Language:
English
Journal:
J Hosp Med
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS